Patients’ background demographic and clinical characteristics at the time of breast cancer diagnosis.

1 25 patients had mastectomy with breast reconstruction2 AC- doxorubicin+cyclophosphamide; CMF- cyclophosphamide+methotrexate+fluorouracil; T- paclitaxel, numbers indicated number of cycles received; ‘Others’ included 8 patients who had anthracycline-taxane containing regimens other than AC-T, 4 who did not complete CMF x 6, 1 who did not complete AC x 4, 1 who had paclitaxel x 4 only, 1 who had docetaxel+ cyclophosphamide x 4 and 1 who had CMF x 1 and paclitaxel x 4.The BMI results were divided into four categories according to WHO criteria [17].Patients’ background demographic and clinical characteristics at the time of breast cancer diagnosis.